Praveen K Bommareddy
10PUBLICATIONS
58CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Jul 08, 2025
RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE).Michael K Wong, Mohammed M Milhem, Joseph J Sacco
|Apr 08, 2025
The Society for Immunotherapy of Cancer Perspective on Liquid Biopsy- and Radiomics-Based Technologies for Immuno-oncology Biomarker Discovery and Application.Anne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas
|Dec 03, 2024
The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and Application.Anne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas
|Apr 10, 2024
Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival.Praveen K Bommareddy, Hiroaki Wakimoto, Robert L Martuza
|Jul 11, 2023
Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer.Sachin R Jhawar, Shang-Jui Wang, Aditya Thandoni
|Feb 05, 2022
Publisher Correction: Autophagy promotes growth of tumors with high mutational burden by inhibiting a T-cell immune response.Laura Poillet-Perez, Daniel W Sharp, Yang Yang
Pageof 2
Frequent Collaborators
4 joint publications
Samuel D Rabkin
4 joint publications
Howard L Kaufman
2 joint publications
Andrew Zloza
2 joint publications
Yang Yang
2 joint publications
Saurabh V Laddha
2 joint publications
Joshua D Rabinowitz
2 joint publications
Jian Cao
2 joint publications
Jun-Lin Guan
2 joint publications
Edmund C Lattime
2 joint publications
Eileen White
